Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 388 Results Clear All
UCSF Magazine—Insights from human evolution—including Gladstone scientist Katie Pollard’s discovery of the fast-evolving parts of our genome—could change how we understand and treat illness.
Gladstone Experts Data Science and Biotechnology Pollard Lab
Cell Press—Gladstone Investigator Nevan Krogan, who was selected as one of the Cell Press 50 Scientists that Inspire, discusses how new technologies can break down barriers in research and reveal more commonalities across different disease areas than currently known.
Gladstone Experts Krogan Lab
StudyFinds—Scientists in Jorge Palop’s lab have developed a cutting-edge technology that could transform how we identify Alzheimer’s years before traditional symptoms become obvious.
Gladstone Experts Alzheimer’s Disease Neurological Disease Palop Lab
Drug Discovery World—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, is featured for his innovative work using CRISPR genome editing to develop better cellular therapies for cancer, silencing genes that cause immune cells to become exhausted and activating genes that help them be more effective.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
Labroots—Gladstone scientist Yadong Huang comments on his recent study that shows how microglia and APOE4 interact to promote important aspects of Alzheimer’s disease.
Gladstone Experts Alzheimer’s Disease Neurological Disease Huang Lab
Science—In this Perspective article in Science, Gladstone investigator Christina Theodoris shares insights on a new AI model known as Evo that can deduce how bacterial and viral genomes operate—and then use that information to design new proteins and even whole microbial genomes. (Subscription required.)
Gladstone Experts Theodoris Lab AI
Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.
Gladstone Experts Yamanaka Lab Stem Cells/iPSCs
ABC7 News—The most commonly reported symptom of long COVID is brain fog, which interferes with your ability to think clearly, remember things, and focus on a task. Senior Investigator Katerina Akassoglou explains the findings from her study that shed new light on what causes brain fog and the many other brain-related symptoms of long COVID and COVID-19.
Gladstone Experts COVID-19 Akassoglou Lab
San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.
Gladstone Experts Srivastava Lab
University of San Francisco—Students in the Master’s in Biotechnology program at the University of San Francisco visited Gladstone to learn about industry-altering scientific breakthroughs and met with Benoit Bruneany, director of the Gladstone Institute of Cardiovascular Disease, and Stephen Freedman, vice president of corporate liaison and ventures.
Gladstone Experts
Genetic Engineering & Biotechnology News—Gladstone Investigator Seth Shipman and his team developed a new technology using retrons to engineer bacteria-fighting viruses known as phages, which could be used to kill antibiotic-resistant bacteria.
Gladstone Experts Shipman Lab
Inside Precision Medicine—A new study by Gladstone Senior Investigators Katerina Akassoglou and Warner Greene shows that fibrin, a blood coagulation protein, drives the cascade of symptoms that are the hallmarks of infection by the SARS-CoV-2 virus.
Gladstone Experts COVID-19 Akassoglou Lab
Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.
Gladstone Experts Infectious Disease Doudna Lab
The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.
Gladstone Experts Infectious Disease Ott Lab
The Stem Cellar—CIRM intern Josh Nelson shares how he went from working as a technical director for various theaters to pursuing a science career, and explains the work he does in Bruce Conklin’s lab at Gladstone.
Gladstone Experts
